共 50 条
- [1] Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trialCYTOTHERAPY, 2021, 23 (10) : 931 - 938You, DalsanJang, Myoung JinSong, GeehyunShin, Ha ChulSuh, NayoungKim, Yong ManAhn, Tai YoungKim, Choung-Soo
- [2] Safety and Potential Therapeutic Effect of Two Intracavernous Autologous Bone Marrow Derived Mesenchymal Stem Cells injections in Diabetic Patients with Erectile Dysfunction: An Open Label Phase I Clinical TrialUROLOGIA INTERNATIONALIS, 2018, 101 (03) : 358 - 365Al Demour, SaddamJafar, HananAdwan, SofiaAlSharif, AbedallatifAlhawari, HussamAlrabadi, AdelZayed, AymanJaradat, AhmadAwidi, Abdalla
- [3] Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clinical trialBASIC AND CLINICAL ANDROLOGY, 2024, 34 (01)Al Demour, SaddamAdwan, SofiaJafar, HananAlhawari, HussamAwidi, Abdalla
- [4] Safety and Feasibility of Intravenous Autologous Bone Marrow Derived Stem Cell Therapy for Patients with Acute Ischaemic Stroke: An Open-Label, Phase I TrialNEUROLOGY, 2010, 74 (09) : A509 - A510Prasad, KameshwarBhatia, RohitMohanty, SujataSrivastava, M. V. PadmaGarg, AjaySrivastava, AchalGoyal, VinayTripathi, ManjariKumar, AmitVij, ArtiMisra, N. K.Bal, C. S.
- [5] Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical TrialCELL JOURNAL, 2019, 20 (04) : 592 - 598Nabavi, Seyed MassoodArab, LeilaJarooghi, NedaBolurieh, TinaAbbasi, FatemehMardpour, SouraAzimyian, VajiheMoeininia, FatemehMaroufizadeh, SamanSanjari, LeilaHosseini, Seyedeh EsmatAghdami, Nasser
- [6] Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical TrialEBIOMEDICINE, 2016, 5 : 204 - 210Haahr, Martha KirstineJensen, Charlotte HarkenToyserkani, Navid MohamadpourAndersen, Ditte CarolineDamkier, PerSorensen, Jens AhmLund, LarsSheikh, Soren Paludan
- [7] Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trialCYTOTHERAPY, 2014, 16 (06) : 810 - 820Mancias-Guerra, ConsueloRosa Marroquin-Escamilla, AlmaGonzalez-Llano, OscarVillarreal-Martinez, LauraCarlos Jaime-Perez, JoseGarcia-Rodriguez, FernandoLisete Valdes-Burnes, SagrarioNely Rodriguez-Romo, LauraCatalina Barrera-Morales, DinorahJavier Sanchez-Hernandez, JoseGraciela Cantu-Rodriguez, OlgaHomero Gutierrez-Aguirre, CesarGomez-De Leon, AndresElizondo-Riojas, GuillermoSalazar-Riojas, RosarioGomez-Almaguer, David
- [8] An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patientsNeurological Sciences, 2022, 43 : 399 - 410Rashin MohseniAmir Ali HamidiehAlireza Shoae-HassaniMasood Ghahvechi-AkbariAnahita MajmaMahmoud MohammadiMahin NikougoftarReza Shervin-BadvJafar AiHadi MontazerlotfelahiMahmoud Reza Ashrafi
- [9] An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patientsNEUROLOGICAL SCIENCES, 2022, 43 (01) : 399 - 410Mohseni, RashinHamidieh, Amir AliShoae-Hassani, AlirezaGhahvechi-Akbari, MasoodMajma, AnahitaMohammadi, MahmoudNikougoftar, MahinShervin-Badv, RezaAi, JafarMontazerlotfelahi, HadiAshrafi, Mahmoud Reza
- [10] Transplantation With Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 TrialHEPATOLOGY, 2016, 64 (06) : 2185 - 2197Suk, Ki TaeYoon, Jung-HwanKim, Moon YoungKim, Chang WookKim, Ja KyungPark, HanaHwang, Seong GyuKim, Dong JoonLee, Byung SeokLee, Sae HwanKim, Hong SooJang, Jae YoungLee, Chang-HyeongKim, Byung SeokJang, Yoon OkCho, Mee YonJung, Eun SunKim, Yong ManBae, Si HyunBaik, Soon Koo